Dynamic skeletal traction spica casts for paediatric femoral fractures in a resource-limited setting

Andrew R Hsu1, Hilario M Diaz, Noel Rex P Penaranda

  • 1Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA 94304-5709, USA. andyhsu1@gmail.com

Insights

Dynamic skeletal traction spica casting (DSTSC) is a cost-effective alternative to elastic intramedullary nailing (EIN) for pediatric femoral fractures in resource-limited settings. DSTSC offers comparable radiographic outcomes with shorter hospital stays and reduced costs.

Area of Science:

  • Orthopedic surgery
  • Pediatric orthopedics
  • Trauma care

Background:

  • Femoral fractures are common in children.
  • Treatment options include elastic intramedullary nailing (EIN) and dynamic skeletal traction spica casting (DSTSC).
  • Resource-limited settings present unique challenges for orthopedic interventions.

Purpose of the Study:

  • To compare the efficacy of EIN versus DSTSC for pediatric femoral fractures.
  • To evaluate postoperative radiographic angulation, hospital stay duration, and cost.
  • To assess treatment feasibility in resource-limited healthcare environments.

Main Methods:

  • Prospective study of 51 children (5-12 years) with femoral fractures.
  • Patients were treated with either EIN (n=26) or DSTSC (n=25).
  • Outcomes measured included radiographic angulation, hospital stay, and cost.

Main Results:

  • Both EIN and DSTSC achieved acceptable radiographic angulations at 12 weeks.
  • DSTSC group had significantly shorter hospital stays (6.0 days) than EIN group (17 days).
  • EIN treatment was approximately 400% more expensive and had longer pre-operative delays due to supply issues.

Conclusions:

  • Dynamic skeletal traction spica casting (DSTSC) is an effective and more economical alternative to elastic intramedullary nailing (EIN) for pediatric femoral fractures.
  • DSTSC leads to reduced hospital stays and lower costs in resource-limited settings.
  • Comparable radiographic outcomes support DSTSC as a viable treatment option.